Andrea S. Wolf, MD, William G. Richards, PhD, Michael T

Slides:

Advertisements

Similar presentations

Elizabeth A. David, MD, David T

Advertisements

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Thomas J. Birdas, MD, Richard P. M

True Negative Predictive Value of Endobronchial Ultrasound in Lung Cancer: Are We Being Conservative Enough? Bryan A. Whitson, MD, PhD, Shawn S. Groth,

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis Amgad El-Sherif, MD, William E. Gooding, MS,

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non–small cell lung cancer Kamran.

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non- Small Cell Lung Cancer Ken Kodama, MD, Masahiko Higashiyama, MD, Jiro.

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery

Non-Small Cell Lung Cancer Resection in Lymphoma Patients

Castigliano M. Bhamidipati, DO, MS, George J

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

A Comparison of Length of Stay, Readmission Rate, and Facility Reimbursement After Lobectomy of the Lung Richard K. Freeman, MD, MBA, J. Russell Dilts,

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Surgical Treatment of Metachronous Second Primary Lung Cancer

Andrea S. Wolf, MD, MPH, Scott J

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Positron Emission Tomography-Computed Tomography for Postoperative Surveillance in Non-Small Cell Lung Cancer Se Hoon Choi, MD, Young Tae Kim, MD, PhD,

Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival Daniel L. Miller, MD, William R. Mayfield, MD,

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer Usman Ahmad, MD, Traves D. Crabtree,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy Arya Amini, BA, Arlene.

Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis Bryan A. Whitson, MD, PhD, Shawn S.

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

VATS Lobectomy Has Better Perioperative Outcomes Than Open Lobectomy: CALGB 31001, an Ancillary Analysis of CALGB (Alliance) Chukwumere E. Nwogu,

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Open, Video-Assisted Thoracic Surgery, and Robotic Lobectomy: Review of a National Database Michael Kent, MD, Thomas Wang, PhD, Richard Whyte, MD, Thomas.

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey.

Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy Haiyu Zhou, MD, Luis F. Tapias, MD, Henning A.

Characteristics of Malignant Pleural Mesothelioma in Women

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

Sequential thoracic metastasectomy prolongs survival by re-establishing local control within the chest Michael T. Jaklitsch, MDa, Carlos M. Mery, MDa,

Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection Emilie Perrot, MD, Benoit Guibert, MD, Pierre Mulsant,

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

The Annals of Thoracic Surgery

Modified T-Tube Repair of Delayed Esophageal Perforation Results in a Low Mortality Rate Similar to That Seen With Acute Perforations Philip A. Linden,

Sequential Design for Clinical Trials Evaluating a Prosthetic Heart Valve Cody Hamilton, PhD, Michael Lu, PhD, Steven Lewis, PhD, William Anderson, PhD

Specialty Training and Mortality After Esophageal Cancer Resection

Menopausal effects on presentation, treatment, and survival of women with non–small cell lung cancer Kimberly A Moore, MD, Carlos M Mery, MD, MPH, Michael.

Philip A. Linden, MD, Jon O. Wee, MD, Michael T

Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural.

Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection Daniel L. Miller, MD, Gerald A. Helms, MD,

Matthew J. Schuchert, MD, Omar Awais, DO, Ghulam Abbas, MD, Zachary D

Mert Saynak, MD, Jessica Hubbs, MS, Jiho Nam, MD, Lawrence B

Lobectomy for Lung Cancer at Veterans Administration Medical Center Versus Academic Medical Center Travis Geraci, MD, Vanessa Baratta, MD, John Young,

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Bryan M. Burt, MD, Santiago Ocejo, MD, Carlos M

Presentation transcript:

Lobectomy Versus Sublobar Resection for Small (2 cm or Less) Non–Small Cell Lung Cancers Andrea S. Wolf, MD, William G. Richards, PhD, Michael T. Jaklitsch, MD, Ritu Gill, MD, Lucian R. Chirieac, MD, Yolonda L. Colson, MD, PhD, Kamran Mohiuddin, MD, Steven J. Mentzer, MD, Raphael Bueno, MD, David J. Sugarbaker, MD, Scott J. Swanson, MD The Annals of Thoracic Surgery Volume 92, Issue 5, Pages 1819-1825 (November 2011) DOI: 10.1016/j.athoracsur.2011.06.099 Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Cumulative survival distribution for overall survival (A) and recurrence-free survival (B) grouped by type of resection. The Annals of Thoracic Surgery 2011 92, 1819-1825DOI: (10.1016/j.athoracsur.2011.06.099) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Cumulative survival distribution for overall survival for lobectomy and sublobar resection, the latter stratified by lymph node sampling. The Annals of Thoracic Surgery 2011 92, 1819-1825DOI: (10.1016/j.athoracsur.2011.06.099) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Cumulative survival distribution for recurrence-free survival for lobectomy and sublobar resection, the latter stratified by lymph node sampling. The Annals of Thoracic Surgery 2011 92, 1819-1825DOI: (10.1016/j.athoracsur.2011.06.099) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions